Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
about
Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG islandDNA damage, homology-directed repair, and DNA methylationA role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 geneThe prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancerGenome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complexDACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modificationsEpigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancerDNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinomaEGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatmentAn overview of epigenetics and chemopreventionLINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking ChineseDNA methylation screening identifies driver epigenetic events of cancer cell survivalDNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cellsEpigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancerThe human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shoresEpigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaField defects in progression to gastrointestinal tract cancersMitf regulation of Dia1 controls melanoma proliferation and invasivenessEpigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated HepatocarcinogenesisSignaling Pathways in Thyroid Cancer and Their Therapeutic ImplicationsEpigenetic treatment of solid tumours: a review of clinical trialsIntegration of genome scale data for identifying new players in colorectal cancerHelicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditionsThe cancer epigenome: its origins, contributions to tumorigenesis, and translational implicationsCommon features of chromatin in aging and cancer: cause or coincidence?The significance of genetics for cholangiocarcinoma developmentEpigenetics in breast cancer: what's new?Epigenetics advancing personalized nanomedicine in cancer therapyPhenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 miceHost epigenetic modifications by oncogenic virusesGene expression and hepatitis C virus infectionStem cells, senescence, neosis and self-renewal in cancer.Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancerDNA methylation, its mediators and genome integrityTumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cellsEpigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesisCD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancerThe epigenomics of cancerDetection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesionsAsbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma
P2860
Q21092482-88D82D79-4680-4F8F-B5D5-9E37B05A7F3FQ21092492-D867ED5D-D22C-4C8A-8FE3-044FCBBBD708Q21142628-23C0F62F-EC1F-448E-A1D1-9140D0CC66BAQ24310299-7C156C31-DE1D-460E-A347-6DF9E9DC39A9Q24313142-C0558DCB-4B4A-403F-83AE-B5D245FA2AB1Q24319915-0C85B9E5-5224-4E66-B510-620C95347221Q24321845-AEFC664A-D90E-42B5-A920-2F0158A4D6FDQ24606042-09DBF101-5A1F-4D53-BDCB-52DDE08C7C7FQ24616455-497D340D-526E-4E45-A4EA-95D18CC5DE10Q24623823-77650CF4-3A4A-4328-9A12-8CE7217E5274Q24631578-43461CCD-02F8-4310-A297-F7ED04145896Q24632287-DF5D4322-85BA-4936-8BF2-139206B3427EQ24644027-71265FC0-CF5B-4482-830E-15BFD09477DAQ24645509-0A0052B2-ABEC-4CB7-950D-ADD1652D002EQ24649374-43B6E6B0-E7F0-4454-8005-F8E5E05A2E16Q24652017-0E01C0BC-F788-4DA9-BB59-A9439233A7CCQ24653877-B4D72EC7-E871-4EA5-8C63-9EAD4D2BDF94Q24672631-6408ADD8-381A-454C-B321-ED239584A4FBQ26739018-ED704B0E-6EC3-4F25-B591-B8E639D7801CQ26764899-1FB5C1C0-2757-4CD3-9D6C-B347D1C129AEQ26773803-FD507412-B59C-4A7B-A7FA-4A5CCBE2FDD7Q26774701-EBDB9B86-C9A6-4797-AC14-BEED3023C681Q26782813-B0AFCC5B-2E10-475E-B623-0A11843397F3Q26828751-89707AD1-80B6-4892-9BA5-3EFEE2B571AFQ26864051-A935555B-5CC6-46DD-A9AB-2A9578F90E5DQ26865749-17A9402C-3718-463B-889A-DEBD941C6F73Q26991779-DB81AA59-CC0C-404E-8179-9910DD28B47EQ27010637-5983870B-574C-460A-9F52-625B9AB01960Q27349142-DB24C228-4616-4A91-A6E6-AC9CF5BD60F4Q27485909-A61C6815-0FF8-4754-B159-24CC78D458C2Q27488345-F4A2DF66-B4AE-414A-8517-746A752FA57AQ27497212-02E1D426-3715-4328-AE1F-D9C5137291E8Q28069755-8E5B0A53-1E6E-4FB6-8552-02FB1868CAD5Q28080760-A9E0575B-CB0D-441D-B188-3425D510487EQ28249223-7CBF4499-582D-448F-8AF6-4473C6FCDA00Q28264669-4EE2EAE6-B807-4CA9-A130-A5DA653012DEQ28282860-F86E987C-A43D-4F0B-8D78-DB1A3B16BBBEQ28289975-BDC8A00F-ED0E-4BE5-ACE5-C12CDE1E881AQ28292507-146E808B-95EA-4B89-9054-A16017C6537FQ28385230-BB68ECC8-B851-4EB1-8B95-1E492AACFBAE
P2860
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@ast
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@en
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@en-gb
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@nl
type
label
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@ast
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@en
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@en-gb
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@nl
altLabel
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
@en
prefLabel
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@ast
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@en
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@en-gb
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@nl
P3181
P356
P1476
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
@en
P2093
Joyce E. Ohm
P2888
P304
P3181
P356
10.1038/NRC1799
P407
P577
2006-02-01T00:00:00Z
P5875
P6179
1041169608